Wojciech Senkowski

675 total citations
14 papers, 331 citations indexed

About

Wojciech Senkowski is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wojciech Senkowski has authored 14 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Wojciech Senkowski's work include Cancer, Hypoxia, and Metabolism (6 papers), Cancer Research and Treatments (3 papers) and Cancer Cells and Metastasis (2 papers). Wojciech Senkowski is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Cancer Research and Treatments (3 papers) and Cancer Cells and Metastasis (2 papers). Wojciech Senkowski collaborates with scholars based in Sweden, Denmark and United States. Wojciech Senkowski's co-authors include Mårten Fryknäs, Rolf Larsson, Peter Nygren, Stig Linder, Xiaonan Zhang, Maria Hägg Olofsson, Urban Höglund, Ruben Isacson, Mats Gustafsson and Claes Andersson and has published in prestigious journals such as Nature Communications, Scientific Reports and Science Advances.

In The Last Decade

Wojciech Senkowski

14 papers receiving 326 citations

Peers

Wojciech Senkowski
Merve Çakır United States
Pey Yee Lee Malaysia
Luwei Liu United States
Bibek Parajuli United States
Yanzhou Zhang Singapore
Guoyan Xu China
Wojciech Senkowski
Citations per year, relative to Wojciech Senkowski Wojciech Senkowski (= 1×) peers Yajing Liu

Countries citing papers authored by Wojciech Senkowski

Since Specialization
Citations

This map shows the geographic impact of Wojciech Senkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wojciech Senkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wojciech Senkowski more than expected).

Fields of papers citing papers by Wojciech Senkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wojciech Senkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wojciech Senkowski. The network helps show where Wojciech Senkowski may publish in the future.

Co-authorship network of co-authors of Wojciech Senkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Wojciech Senkowski. A scholar is included among the top collaborators of Wojciech Senkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wojciech Senkowski. Wojciech Senkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sekhar, Sreeja C., Karan Bedi, Marcin Iwanicki, et al.. (2025). Identification of a TNIK-CDK9 Axis as a Targetable Strategy for Platinum-Resistant Ovarian Cancer. Molecular Cancer Therapeutics. 24(4). 639–656. 1 indexed citations
2.
Ianevski, Aleksandr, Wojciech Senkowski, Daria Bulanova, et al.. (2024). Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clones. Nature Communications. 15(1). 8579–8579. 13 indexed citations
3.
Bulanova, Daria, Wojciech Senkowski, Jaana Oikkonen, et al.. (2024). A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cells. Science Advances. 10(21). eadj1564–eadj1564. 2 indexed citations
4.
Andersson, Claes, Wojciech Senkowski, Christian Bréchot, et al.. (2022). Sorafenib and nitazoxanide disrupt mitochondrial function and inhibit regrowth capacity in three-dimensional models of hepatocellular and colorectal carcinoma. Scientific Reports. 12(1). 8943–8943. 13 indexed citations
5.
Fryknäs, Mårten, et al.. (2022). Selective radiosensitization by nitazoxanide of quiescent clonogenic colon cancer tumour cells. Oncology Letters. 23(4). 123–123. 1 indexed citations
6.
Ölander, Magnus, et al.. (2021). Conditions for maintenance of hepatocyte differentiation and function in 3D cultures. iScience. 24(11). 103235–103235. 18 indexed citations
7.
Steinmetz, Julia, Wojciech Senkowski, Johan Lengqvist, et al.. (2020). Descriptive Proteome Analysis to Investigate Context-Dependent Treatment Responses to OXPHOS Inhibition in Colon Carcinoma Cells Grown as Monolayer and Multicellular Tumor Spheroids. ACS Omega. 5(28). 17242–17254. 7 indexed citations
8.
Senkowski, Wojciech, Mårten Fryknäs, Stig Linder, et al.. (2019). A novel tumor spheroid model identifies selective enhancement of radiation by an inhibitor of oxidative phosphorylation. Oncotarget. 10(51). 5372–5382. 6 indexed citations
9.
Senkowski, Wojciech, Frida Nyberg, Per-Henrik Edqvist, et al.. (2017). Targeting tumor cells based on Phosphodiesterase 3A expression. Experimental Cell Research. 361(2). 308–315. 23 indexed citations
10.
Senkowski, Wojciech, Malin Jarvius, Malin Berglund, et al.. (2017). The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation. Immunopharmacology and Immunotoxicology. 39(4). 199–210. 23 indexed citations
11.
Senkowski, Wojciech, Malin Jarvius, Jenny Rubin, et al.. (2016). Large-Scale Gene Expression Profiling Platform for Identification of Context-Dependent Drug Responses in Multicellular Tumor Spheroids. Cell chemical biology. 23(11). 1428–1438. 28 indexed citations
12.
Fryknäs, Mårten, Xiaonan Zhang, Ulf Bremberg, et al.. (2016). Iron chelators target both proliferating and quiescent cancer cells. Scientific Reports. 6(1). 38343–38343. 57 indexed citations
13.
Senkowski, Wojciech, Xiaonan Zhang, Maria Hägg Olofsson, et al.. (2015). Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer. Molecular Cancer Therapeutics. 14(6). 1504–1516. 118 indexed citations
14.
Kashif, Muhammad, Claes Andersson, Sadia Hassan, et al.. (2015). In vitro discovery of promising anti-cancer drug combinations using iterative maximisation of a therapeutic index. Scientific Reports. 5(1). 14118–14118. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026